DEVICE, SYSTEM AND METHOD FOR SUBCUTANEOUS DRUG DELIVERY
1 Assignment
0 Petitions
Accused Products
Abstract
Embodiments of the present disclosure present systems, methods and devices relate to delivering a drug subcutaneously to a patient. For example, a subcutaneous drug delivery device for use in delivering a drug subcutaneously to a patient can include a needle or cannula configured for delivery of a drug from a drug reservoir to a subcutaneous tissue of a patient.
5 Citations
83 Claims
-
1-63. -63. (canceled)
-
64. A subcutaneous drug delivery device for use in delivering a drug subcutaneously to a patient, the device comprising:
-
a needle or cannula configured for delivery of a drug from a drug reservoir to a subcutaneous tissue of a patient; a treatment element configured to modify delivery of the drug into the circulatory system of the patient by application of a treatment via a surface of skin based on at least one property of the drug and/or at least one property of a drug depot, wherein the drug depot comprises an area of tissue surrounding the needle or cannula; at least one sensor configured to generate at least one signal determinative of the at least one property and generate a sensor signal representative thereof; and a controller to receive the sensor signal and configure treatment by the treatment element based on the at least one property, wherein the at least one property of the drug comprises at least one of a pharmacokinetic and pharmacodynamics profile of the drug. - View Dependent Claims (65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)
-
-
79. A method for delivering a drug subcutaneously to a patient comprising:
-
providing a subcutaneous drug delivery device configured to deliver a drug subcutaneously to a patient, the device comprising; a drug reservoir configured to contain a drug; a needle or cannula configured for delivery of the drug from the drug reservoir to a subcutaneous tissue of the patient; a treatment element configured to modify delivery of the drug into the circulatory system of the patient by application of a treatment via a surface of skin based on at least one property of the drug and/or at least one property of a drug depot, wherein the drug depot comprises an area of tissue surrounding the needle or cannula; at least one sensor configured to generate at least one signal determinative of the at least one property; and a controller to receive the at least one signal and configure treatment by the treatment element based on the at least one property; delivering the drug subcutaneously via at least one of the needle and cannula; determining a concentration of the drug at the drug depot, and wherein the concentration corresponds to at least one signal generated by the sensor; and activating, increasing, decreasing or de-activating the treatment element upon the concentration being different than a desired concentration. - View Dependent Claims (80, 81, 82, 83)
-
Specification